Ayaka Suenaga

1.1k total citations
42 papers, 925 citations indexed

About

Ayaka Suenaga is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ayaka Suenaga has authored 42 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Ayaka Suenaga's work include Protein Interaction Studies and Fluorescence Analysis (20 papers), Drug Transport and Resistance Mechanisms (15 papers) and Hemoglobin structure and function (6 papers). Ayaka Suenaga is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (20 papers), Drug Transport and Resistance Mechanisms (15 papers) and Hemoglobin structure and function (6 papers). Ayaka Suenaga collaborates with scholars based in Japan, Denmark and Australia. Ayaka Suenaga's co-authors include Masaki Otagiri, Ulrich Kragh‐Hansen, Toru Maruyama, Koji Nishi, Hiroshi Watanabe, Keishi Yamasaki, Toru Maruyama, Toshiya Kai, Tsuneo Deguchi and Yasunori Iwao and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Ayaka Suenaga

42 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayaka Suenaga Japan 18 544 215 157 93 85 42 925
Keisuke Nakajou Japan 17 695 1.3× 257 1.2× 171 1.1× 104 1.1× 121 1.4× 21 1.1k
Yogendra Patel United States 15 652 1.2× 84 0.4× 91 0.6× 69 0.7× 177 2.1× 17 1.1k
John A. Turton United Kingdom 18 491 0.9× 112 0.5× 155 1.0× 154 1.7× 23 0.3× 42 1.1k
Fernando Gómez Spain 18 857 1.6× 163 0.8× 122 0.8× 115 1.2× 36 0.4× 56 1.5k
Donald Gantz United States 26 746 1.4× 115 0.5× 102 0.6× 198 2.1× 31 0.4× 59 1.6k
Klaus Altland Germany 27 1.2k 2.3× 207 1.0× 270 1.7× 267 2.9× 178 2.1× 85 1.9k
Chengye Yuan China 19 1.6k 3.0× 265 1.2× 126 0.8× 101 1.1× 34 0.4× 76 2.5k
Inge Schuster Austria 19 336 0.6× 76 0.4× 159 1.0× 70 0.8× 26 0.3× 30 1.2k
Luigi Silvestro Italy 19 358 0.7× 219 1.0× 84 0.5× 98 1.1× 14 0.2× 56 1.1k
Antonella Borrelli Italy 18 901 1.7× 163 0.8× 68 0.4× 87 0.9× 45 0.5× 33 1.4k

Countries citing papers authored by Ayaka Suenaga

Since Specialization
Citations

This map shows the geographic impact of Ayaka Suenaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayaka Suenaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayaka Suenaga more than expected).

Fields of papers citing papers by Ayaka Suenaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayaka Suenaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayaka Suenaga. The network helps show where Ayaka Suenaga may publish in the future.

Co-authorship network of co-authors of Ayaka Suenaga

This figure shows the co-authorship network connecting the top 25 collaborators of Ayaka Suenaga. A scholar is included among the top collaborators of Ayaka Suenaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayaka Suenaga. Ayaka Suenaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishima, Yu, Jun Fang, Ulrich Kragh‐Hansen, et al.. (2014). Tuning of Poly-S-Nitrosated Human Serum Albumin as Superior Antitumor Nanomedicine. Journal of Pharmaceutical Sciences. 103(7). 2184–2188. 13 indexed citations
2.
Iwao, Yasunori, Yu Ishima, Junji Yamada, et al.. (2012). Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants. IUBMB Life. 64(5). 450–454. 50 indexed citations
3.
Kadowaki, Daisuke, Hiroshi Nonoguchi, Sumío Hirata, et al.. (2011). Toxicodynamic Evaluation of a Cisplatin–Chondroitin Sulfate Complex Using a Perfused Kidney and Human Proximal Tubular Cells. Renal Failure. 33(6). 609–614. 2 indexed citations
4.
Nishi, Koji, Teruya Nakamura, Hiroshi Watanabe, et al.. (2011). Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human α1-Acid Glycoprotein Genetic Variants, the A and F1*S Forms. Journal of Biological Chemistry. 286(16). 14427–14434. 74 indexed citations
5.
Anraku, Makoto, Daisuke Kadowaki, Teruko Imai, et al.. (2011). Spectroscopic studies of interactions of chondroitin sulfates with cisplatin. Carbohydrate Research. 346(5). 631–637. 6 indexed citations
6.
Nishi, Koji, Teruo Akuta, Daisuke Kadowaki, et al.. (2009). A Site-Directed Mutagenesis Study of Drug-Binding Selectivity in Genetic Variants of Human α1-Acid Glycoprotein. Journal of Pharmaceutical Sciences. 98(11). 4316–4326. 13 indexed citations
7.
Iwao, Yasunori, Ulrich Kragh‐Hansen, Keiichi Kawai, et al.. (2008). Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(4). 634–641. 14 indexed citations
8.
Chuang, Victor Tuan Giam, Keishi Yamasaki, Kohichi Kawahara, et al.. (2007). Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin. Drug Metabolism and Disposition. 36(1). 81–86. 14 indexed citations
9.
Nishi, Koji, et al.. (2007). Structural and ligand‐binding properties of serum albumin species interacting with a biomembrane interface. Journal of Pharmaceutical Sciences. 96(11). 3117–3124. 9 indexed citations
10.
Iwao, Yasunori, Makoto Anraku, Keiichi Kawai, et al.. (2006). The Structural and Pharmacokinetic Properties of Oxidized Human Serum Albumin, Advanced Oxidation Protein Products (AOPP). Drug Metabolism and Pharmacokinetics. 21(2). 140–146. 68 indexed citations
11.
Chuang, Victor Tuan Giam, Sumio Tanase, Keiichi Kawai, et al.. (2006). Recombinant Human Serum Albumin Dimer has High Blood Circulation Activity and Low Vascular Permeability in Comparison with Native Human Serum Albumin. Pharmaceutical Research. 23(5). 882–891. 43 indexed citations
12.
Deguchi, Tsuneo, et al.. (2005). Renal Clearance of Endogenous Hippurate Correlates with Expression Levels of Renal Organic Anion Transporters in Uremic Rats. Journal of Pharmacology and Experimental Therapeutics. 314(2). 932–938. 68 indexed citations
13.
Chuang, Victor Tuan Giam, et al.. (2004). Tryptophan Residues Play an Important Role in the Extraordinarily High Affinity Binding Interaction of UCN-01 to Human α-1-Acid Glycoprotein. Pharmaceutical Research. 21(9). 1648–1655. 13 indexed citations
14.
Harada, Daisuke, Makoto Anraku, Shinsaku Naito, et al.. (2004). Kinetic Studies of Covalent Binding between N-acetyl-L-cysteine and Human Serum Albumin Through a Mixed-disulfide Using an N-methylpyridinium Polymer-based Column. Drug Metabolism and Pharmacokinetics. 19(4). 297–302. 33 indexed citations
15.
Imai, Teruko, et al.. (2002). Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C. International Journal of Pharmaceutics. 240(1-2). 23–31. 29 indexed citations
16.
Matsumoto, Kazuaki, et al.. (2002). Characterization of Ligand Binding Sites on the α1-Acid Glycoprotein in Humans Bovines and Dogs. Drug Metabolism and Pharmacokinetics. 17(4). 300–306. 43 indexed citations
17.
Imamura, Hitoshi, et al.. (2002). Stereoselective protein binding of alprenolol in the renal diseased state. Chirality. 14(7). 599–603. 7 indexed citations
18.
Nishi, Koji, et al.. (2000). Characterization of a Binding Site of UCN-01, a Novel Anticancer Drug on .ALPHA.1-Acid Glycoprotein.. Biological and Pharmaceutical Bulletin. 23(7). 893–895. 5 indexed citations
19.
Takamura, Norito, et al.. (1998). Effects of Fatty Acids on Serum Binding between Furosemide and Valproic Acid.. Biological and Pharmaceutical Bulletin. 21(2). 174–176. 23 indexed citations
20.
Takamura, Norito, et al.. (1997). Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins. Pharmaceutical Research. 14(4). 522–526. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keisuke Nakajou Breakdown of academic impact, for papers by Yogendra Patel Breakdown of academic impact, for papers by John A. Turton Breakdown of academic impact, for papers by Fernando Gómez Breakdown of academic impact, for papers by Donald Gantz Breakdown of academic impact, for papers by Klaus Altland Breakdown of academic impact, for papers by Chengye Yuan Breakdown of academic impact, for papers by Inge Schuster Breakdown of academic impact, for papers by Luigi Silvestro Breakdown of academic impact, for papers by Antonella Borrelli
Rankless by CCL
2026